Konstantin G. Arbeev

Konstantin G. Arbeev

Auto-generated profile, based on publicly available information

Konstantin G. Arbeev

Biodemography of Aging Research Unit, Social Science Research Institute, Duke University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Mechanisms of Ageing and Development
Verified
Journal Article
Open access
SUSvetlana Ukraintseva
Svetlana Ukraintseva
KAKonstantin Arbeev
Konstantin Arbeev
MDMatt Duan
Matt Duan
IAIgor V. Akushevich
Igor V. Akushevich
AKAlexander Kulminski
Alexander Kulminski
AYAnatoliy I. Yashin
Anatoliy I. Yashin
Decline in biological resilience (ability to recover) is a key manifestation of aging that contributes to increase in vulnerability to death with age eventually limiting longevity even in people without major chronic diseases. Understanding the mechanisms of this decline is essential for developing efficient anti-aging and pro-longevity interventions. In this paper we discuss: a) mechanisms of the decline in resilience with age, and aging components that contribute to this decline, including depletion of body reserves, imperfect repair mechanisms, and slowdown of physiological processes and responses with age; b) anti-aging interventions that may improve resilience or attenuate its decline; c) biomarkers of resilience available in human and experimental studies; and d) genetic factors that could influence resilience. There are open questions about optimal anti-aging interventions that would oppose the decline in resilience along with extending longevity limits. However, the area develops quickly, and prospects are exciting.

5 February 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
KAKonstantin G. Arbeev
Konstantin G. Arbeev
SVSimon Verhulst
Simon Verhulst
TSTroels Steenstrup
Troels Steenstrup
JKJeremy D. Kark
Jeremy D. Kark
OBOlivia Bagley
Olivia Bagley
AAAbraham Aviv
Abraham Aviv
The debate on the natural life span limit in humans has focused on demographic trends1-5 rather than on biological factors that set a ceiling for life span. We hypothesized that leukocyte telomere length (LTL) might be a biological driver of life span because LTL is associated with increased mortality among older individuals6-10 and converging evidence infers a causal role of LTL in aging-related diseases that often result in death.11-15

27 January 2012 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
IAIgor V. Akushevich
Igor V. Akushevich
JKJulia Kravchenko
Julia Kravchenko
SUSvetlana Ukraintseva
Svetlana Ukraintseva
KAKonstantin Arbeev
Konstantin Arbeev
AYAnatoliy I. Yashin
Anatoliy I. Yashin

22 June 2018 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
KAKonstantin G Arbeev
Konstantin G Arbeev
SUSvetlana V Ukraintseva
Svetlana V Ukraintseva
OBOlivia Bagley
Olivia Bagley
IZIlya Y Zhbannikov
Ilya Y Zhbannikov
ACAlan A Cohen
Alan A Cohen
AYAnatoliy I Yashin
Anatoliy I Yashin
Recently suggested novel implementation of the statistical distance measure (DM) for evaluating “physiological dysregulation” (PD) in aging individuals (based on measuring deviations of multiple biomarkers from baseline or normal physiological states) allows reducing high-dimensional biomarker space into a single PD estimate. Here we constructed DM using biomarker profiles from FRAMCOHORT (Framingham Heart Study) and CHS (Cardiovascular Health Study) Research Materials obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center, and estimated effect of PD on total survival, onset of unhealthy life (proxy for “robustness”) and survival following the onset of unhealthy life (proxy for “resilience”). We investigated relationships between PD and declines in stress resistance and adaptive capacity not directly observed in data. PD was more strongly associated with the onset of unhealthy life than with survival after disease suggesting that declines in robustness and resilience with age may have overlapping as well as distinct mechanisms. We conclude that multiple deviations of physiological markers from their normal states (reflected in higher PD) may contribute to increased vulnerability to many diseases and precede their clinical manifestation. This supports potential use of PD in health care as a preclinical indicator of transition from healthy to unhealthy state.

30 July 2019 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
JWJonathan Wagner
Jonathan Wagner
RKRaphael Knaier
Raphael Knaier
DIDenis Infanger
Denis Infanger
KAKonstantin Arbeev
Konstantin Arbeev
MBMatthias Briel
Matthias Briel
Arno Schmidt-TrucksässArno Schmidt-Trucksäss
Arno Schmidt-Trucksäss
Cardiovascular (CV) diseases including heart failure are the leading causes of morbidity, with age being the primary risk factor. The combination of age-related organic functional impairment and reduced physical fitness can drastically impact an individual’s healthspan. One’s lifespan can potentially be prolonged by the preservation or improvement of physical fitness. However, it remains unclear as to which biomarkers are most suitable for distinguishing between healthy aging and the impaired organ function associated with heart failure. Therefore, a comprehensive assessment of the components of physical fitness and CV function will be performed to identify the most important factors contributing to aging in relation to both health and disease. This cross-sectional investigation will consist of two parts: COmPLETE-Health (C-Health) and COmPLETE-Heart (C-Heart). C-Health will examine the aging trajectories of physical fitness components and CV properties in a healthy population sample aged between 20 and 100 years (n = 490). Separately, C-Heart will assess the same markers in patients at different stages of chronic heart failure (n = 80). The primary outcome to determine the difference between C-Health and C-Heart will be cardiorespiratory fitness as measured by cardiopulmonary exercise testing on a bicycle ergometer. Secondary outcomes will include walking speed, balance, isometric strength, peak power, and handgrip strength. Physical activity as a behavioural component will be assessed objectively via accelerometry. Further, CV assessments will include pulse wave velocity; retinal, arterial, and venous diameters; brachial and retinal arterial endothelial function; carotid intima-media thickness; and systolic and diastolic function. The health distances for C-Health and C-Heart will be calculated using the methodology based on statistical (Mahalanobis) distance applied to measurements of quantitative biomarkers. This research seeks to identify physical fitness and CV biomarkers that best resemble underlying CV risk with age. Further, it will examine which physical fitness markers are impaired most in heart failure. The presented integrative approach could define new recommendations for diagnostic guidance in aging. Ultimately, this study is expected to offer a better understanding of which functional characteristics should be specifically targeted in primary and secondary prevention to achieve an optimal healthspan.

1 June 2016 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
KAKonstantin G. Arbeev
Konstantin G. Arbeev
SUSvetlana V. Ukraintseva
Svetlana V. Ukraintseva
AYAnatoliy I. Yashin
Anatoliy I. Yashin